retatrutide fda status 2025 Promises Big Weight Loss, but Safety Remains a Question Retatrutide Availability and Current Status:

This is the only official government-published drug-specific PA timeline dataset available for 2026 and the most specific named source for GLP-1 PA timelines in any RCM article

12, 2026 (GLOBE NEWSWIRE) -- Disclaimer: This article is for informational purposes only and does not constitute medical advice

The Once-Weekly Regimen For most prescribed semaglutide medications, the recommended dosing schedule involves a single injection per week

Vittone, J., et al

Updated 2022 guidance available at: El Khoudary SR, Aggarwal B, Beckie TM, et al

For global teams, Benepass advises on compliant weight health program design and administration across regions, helping employers apply a consistent strategy without losing local control